Frontiers in Oncology (Jan 2020)

Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

  • Giselle V. Ripoll,
  • Giselle V. Ripoll,
  • Marina Pifano,
  • Juan Garona,
  • Juan Garona,
  • Daniel F. Alonso,
  • Daniel F. Alonso

DOI
https://doi.org/10.3389/fonc.2019.01490
Journal volume & issue
Vol. 9

Abstract

Read online

No abstracts available.

Keywords